Anna Zein-El-Din

Dr. Anna Zein-El-Din


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Georges MaaloulyGeorges Maalouly
Georges Maalouly
Youakim SalibaYouakim Saliba
Youakim Saliba
JHJoelle Hajal
Joelle Hajal
AZAnna Zein-El-Din
Anna Zein-El-Din
LFLuana Fakhoury
Luana Fakhoury
NFNassim Fares
Nassim Fares
Background: The pathogenesis of neuropsychiatric lupus erythematosus (NPSLE) is very complex and is associated with neuroinflammation and blood–brain barrier compromise. Experimental investigations of NPSLE have classically relied on spontaneous models. Recently, TLR7 agonist-induced lupus has been shown to exhibit similar neuropsychiatric manifestations to spontaneous ones. Cinnamon is a widespread spice and natural flavoring agent. It has been proven to modulate vascular endothelial tight junctions, neuroinflammation, and autoimmunity pathways, but it has never been tested in relation to lupus. Hypothesis/Purpose: In this pilot study, we aimed to explore the disease-modifying effect of Cinnamomum cassia on NPSLE in a TLR7 agonist-induced model. Study Design: An experimental design was followed in this study. Methods: Lupus was induced in C57BL/6J female mice via the direct application of imiquimod, a TLR7 agonist (5% imiquimod cream, 1.25 mg three times weekly), to the skin. Mice were divided into five groups (n = 8 per group): a sham group (S), a sham group supplemented with cinnamon (SC), an imiquimod-treated group (L), an imiquimod-treated group supplemented with cinnamon starting from induction (LC), and an imiquimod-treated group supplemented with cinnamon beginning two weeks prior to induction (CLC). This protocol was followed for six consecutive weeks. Cinnamomum cassia powder was administered orally at 200 mg/kg, 5 days per week. Results: Behavioral alterations were significantly ameliorated in the CLC group compared to lupus mice. Neuronal shrinkage and nuclear chromatin condensation were visible in the hippocampal cornu ammonis and dentate gyrus zones of lupus mice, with an increased expression of TLR7 and NLRP3, versus significantly less neurodegeneration and TLR7 and NLRP3 expression in the CLC group. In addition, the expression of the blood–brain barrier endothelial cell tight junction proteins claudin-1, occludin, and ZO-1 was abnormally modified in lupus mice and was restored in the CLC group. Moreover, while the cell–cell border delocalization of claudin-1 was documented in cultured blood–brain barrier endothelial cells treated with the plasma of lupus mice to a punctate intracytoplasmic fluorescence pattern, only cells treated with the plasma of the CLC group exhibited a complete reversal of this redistribution of claudin-1. Finally, cinnamaldehyde seemed to interact with TLR7 at multiple sites. Conclusions:Cinnamomum cassia seems to alleviate the pathogenesis of NPSLE. Supplementation with Cinnamomum cassia could be of great interest to modulate the activity and severity of the disease.

1 January 2025 in Journal of Cataract & Refractive Surgery Online Case Reports
Verified
Journal Article
Open access
AZAnna Zein-El-Din
Anna Zein-El-Din
DSDany Salik
Dany Salik
Introduction: A case of traumatic epitheliostromal erosion after photorefractive keratectomy (PRK) retreatment after laser in situ keratomileusis (LASIK) is reported, highlighting the challenges of managing multiple coexistent refractive surgical complications. Patient and Clinical Findings: A 30-year-old man developed a traumatic epitheliostromal erosion 10 years after PRK retreatment after LASIK presenting multiple complications that posed a therapeutic dilemma. Diagnosis, Intervention, and Outcomes: Owing to persistent corneal haze and epithelial ingrowth, diagnosed clinically and on optical coherence tomography (OCT), and unresponsive to prolonged corticosteroid treatment, transphototherapeutic keratectomy (PTK) with 0.02% mitomycin-C was performed. On follow-up visits, the patient's corrected distance visual acuity improved to 20/15, with clear central cornea and minimal residual peripheral haze. Corneal OCT showed stable central corneal thickness and reduced epithelial thickness as well as stromal irregularities. Conclusions: PRK retreatment after LASIK can pose challenges, making careful risk assessment and advanced management techniques essential for achieving optimal results in complex refractive surgery retreatments. In this case, transPTK successfully treated epithelial ingrowth and corneal haze, improving visual outcomes.

4 July 2024 in Journal of Medical Case Reports
Verified
Journal Article
Open access
AZAnna Zein-El-Din
Anna Zein-El-Din
RARami Abdo
Rami Abdo
AEAmina Elbachti
Amina Elbachti
GBGabriel Boustani
Gabriel Boustani
DSDany Salik
Dany Salik
SPSayeh Pourjavan
Sayeh Pourjavan
Background: Hodgkin’s lymphoma (HL) is an extremely rare cause of ocular inflammation that is usually not considered in the typical workup of uveitis and other eye diseases. A few cases of ocular inflammation were reported previously showcasing HL with absence of typical symptoms of HL at presentation. Acknowledging the potential ocular inflammation associated with HL can prompt ophthalmologists to broaden their diagnostic approach and collaborate with internal medicine departments to investigate this rare yet significant etiology. Case presentation: A 17-year-old Caucasian woman presenting unilateral panuveitis was later diagnosed with HL. The ocular findings were non-necrotizing scleritis, anterior uveitis, vitritis, white/yellowish chorioretinal lesions, papillitis and vasculitis. A left supra-clavicular lymph node biopsy confirmed the diagnosis of nodular sclerosing Hodgkin’s lymphoma stage IIB. Other causes of uveitis were excluded. Chemotherapy led to remission of the disease and the ocular lesions became quiescent with persistent pigmented chorioretinal scars. Conclusions: Hodgkin's lymphoma should be considered in the differential diagnosis of diseases that can occasionally be revealed by unilateral ocular inflammation. A comprehensive, multidisciplinary approach is key to properly assessing such cases.